ScreenerHero

VXL Vaxil Bio Ltd.

TSXV · CA · Healthcare · Biotechnology
0.1450CAD0.00%Mkt Cap: 420703 $P/E: 0.97

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap420.70K USD
Enterprise Value82.79K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)380.15K USD
Revenue/Share—
Last Price0.1450 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA92243L2066
Valuation
P/E (Trailing)0.97
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.46
EPS (TTM)0.15
EPS (Forward)—
52W Range
0.13009% of range0.2900
52W High0.2900 CAD
52W Low0.1300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE38.24%
ROA38.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-115.07K USD
CapEx (TTM)—
FCF Margin—
FCF Yield11.71%
Net Debt-337.91K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio17.97
Quick Ratio17.97
Book Value/Sh0.32 CAD
Cash/Share0.12 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 15, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.98M
Float3.76M
Insiders5.61%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Out.0.00%
Shares Short131
Short (prev mo.)1.00K
Technical
SMA 500.1602 (-9.5%)
SMA 2000.1704 (-14.9%)
Beta-0.33
S&P 52W Chg16.45%
Avg Vol (30d)1.79K
Avg Vol (10d)50
Technical Indicators
RSI (14)26.8
MACD-0.0055
MACD Signal-0.0061
MACD Hist.+0.0006
BB Upper0.1668 CAD
BB Middle0.1492 CAD
BB Lower0.1317 CAD
BB Width23.52%
ATR (14)0.0014 CAD
Vol Ratio (20d)0.28x